Self-assembling micelle-like nanoparticles based on phospholipid-polyethyleneimine conjugates for systemic gene...

Area of Science:

• Biotechnology
• Nanomedicine
• Gene Therapy

Background:

• Effective gene delivery systems are crucial for the clinical application of gene therapies.
• Current methods often face challenges with systemic administration and stability.

Purpose of the Study:

• To develop and characterize a novel non-viral gene delivery vector for systemic gene therapy.
• To evaluate the efficacy and safety of the developed vector in preclinical models.

Main Methods:

• Engineered micelle-like nanoparticles (MNPs) by condensing plasmid DNA with phospholipid-polyethylenimine (PLPEI) and coating with PEG-PE lipid monolayer.
• Assessed DNA protection, salt-induced aggregation resistance, cytotoxicity, blood circulation time, and RES accumulation.
• Evaluated in vivo gene delivery and transfection efficiency in a distal tumor model using GFP plasmid DNA.

Main Results:

• MNPs provided complete DNA protection from enzymatic degradation and resistance to aggregation.
• Demonstrated reduced cytotoxicity, prolonged blood circulation, and low RES accumulation.
• Successfully transfected a distal tumor following intravenous injection of MNP-loaded GFP plasmid DNA.

Conclusions:

• Micelle-like nanoparticles (MNPs) represent a promising non-viral vector for systemic gene therapy.
• MNPs offer enhanced stability, safety, and effective gene delivery to target tissues.
• This novel vector technology has the potential to advance clinical gene therapy applications.